Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome.

abdominal obesity body weight cardiometabolic risks circadian rhythm eating window elevated blood pressure impaired glucose metabolism m-health applications metabolic syndrome time-restricted eating

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Jun 2024
Historique:
received: 04 04 2024
revised: 18 05 2024
accepted: 04 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Metabolic syndrome (MetS) and a prolonged daily eating window (EW) are associated with circadian rhythm disruption and increased cardiometabolic risk. Misalignment between circadian timing system and daily rhythms of food intake adversely impacts metabolic regulatory mechanisms and cardiovascular function. Restricting the daily EW by imposing an eating-fasting cycle through time-restricted eating (TRE) can restore robust circadian rhythms, support cellular metabolism, and improve cardiometabolic health. The aim of this study was to assess a feasibility of 12-week TRE intervention with self-selected 10 h EW and effects of TRE on EW duration, cardiometabolic outcomes, daily rhythms of behavior, and wellbeing in Polish patients with MetS and EW ≥ 14 h/day. Dietary intake was monitored with a validated myCircadianClock application (mCC app). Adherence to TRE defined as the proportion of days recorded with mCC app in which participants satisfied 10-h TRE was the primary outcome. A total of 26 patients (aged 45 ± 13 years, 62% women, 3.3 ± 0.5 MetS criteria, EW 14 ± 1.5 h/day) were enrolled. Coexistence of increased waist circumference (WC) (96% of patients), elevated fasting plasma glucose (FPG) (77%), and elevated blood pressure (BP) (69%) was the most common MetS pattern (50%). TRE intervention (mean duration of 81.6 ± 12.6 days) led to reducing daily EW by 28% (

Identifiants

pubmed: 38931157
pii: nu16121802
doi: 10.3390/nu16121802
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Iwona Świątkiewicz (I)

Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA 92037, USA.

Jarosław Nuszkiewicz (J)

Department of Medical Biology and Biochemistry, Collegium Medicum, Nicolaus Copernicus University, 85-092 Bydgoszcz, Poland.

Joanna Wróblewska (J)

Department of Medical Biology and Biochemistry, Collegium Medicum, Nicolaus Copernicus University, 85-092 Bydgoszcz, Poland.

Małgorzata Nartowicz (M)

Clinical Nutrition Team, Oncology Center-Professor Franciszek Łukaszczyk Memorial Hospital, 85-796 Bydgoszcz, Poland.

Kamil Sokołowski (K)

Department of Medical Biology and Biochemistry, Collegium Medicum, Nicolaus Copernicus University, 85-092 Bydgoszcz, Poland.

Paweł Sutkowy (P)

Department of Medical Biology and Biochemistry, Collegium Medicum, Nicolaus Copernicus University, 85-092 Bydgoszcz, Poland.

Paweł Rajewski (P)

Center for Obesity and Metabolic Disorders Treatment, 85-676 Bydgoszcz, Poland.
Faculty of Health Sciences, University of Health Sciences in Bydgoszcz, 85-067 Bydgoszcz, Poland.

Krzysztof Buczkowski (K)

Department of Family Medicine, Collegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland.

Małgorzata Chudzińska (M)

Department of Nutrition and Dietetics, Collegium Medicum, Nicolaus Copernicus University, 85-626 Bydgoszcz, Poland.

Emily N C Manoogian (ENC)

Regulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Pam R Taub (PR)

Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA 92037, USA.

Alina Woźniak (A)

Department of Medical Biology and Biochemistry, Collegium Medicum, Nicolaus Copernicus University, 85-092 Bydgoszcz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH